Ginkgo Bioworks Holdings, Inc.
$7.88
$0.04 (+0.51%)
$7.50Day Range$7.98
Key Statistics
Market Cap
$527.95M
Shares Outstanding
67.3M
Primary Exchange
XNYS
Currency
USD
Type
CS
IPO Date
Apr 19, 2021
Round Lot
100
Locale
US
Trading Data
Day Open
$7.83
Day High
$7.98
Day Low
$7.50
Volume
1.76M
VWAP
$7.80
Prev Close
$7.84
Transactions
--
Acc. Volume
--
About Ginkgo Bioworks Holdings, Inc.
Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering engaged in providing biological R&D services for customers across a range of industries and Biosecurity that provides services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)SIC 2836485 employees27 DRYDOCK AVENUE, BOSTON, MA, 02210(877) 442-5362IPO Apr 19, 2021US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001830214
- Composite FIGI
- BBG00YPS1KY3
- Share Class FIGI
- BBG00YPS1LT7
- Ticker Root
- DNA
- SIC Code
- 2836
About Ginkgo Bioworks Holdings, Inc. (DNA) Stock
Ginkgo Bioworks Holdings, Inc. (DNA) closed the 2026-09-18 session at $7.88, up 0.51% versus the previous close (+0.04). The stock opened at $7.83 and traded between $7.50 and $7.98 during that session. Session trading volume was 1.8M shares. The volume-weighted average price (VWAP) is $7.80.
Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering engaged in providing biological R&D services for customers across a range of industries and Biosecurity that provides services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.
Ginkgo Bioworks Holdings, Inc. has a market capitalization of $527.9 million. The company operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) industry classification. DNA is listed on the XNYS exchange. The company employs approximately 485 people. Ginkgo Bioworks Holdings, Inc. is headquartered in BOSTON, MA. The recorded listing date is 2021-04-19.
On this page you can find market DNA stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector.